Malignant immunoproliferative diseases

CD2_IMMUNOPROLIFERATIVE

lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 C88
Hospital discharge: ICD-9 $!$
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 C88
Cause of death: ICD-9 $!$
Cause of death: ICD-8 $!$

205

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

205

diagram downward connector

Check minimum number of events None

205

diagram downward connector

Include endpoints None

205

diagram downward connector
CD2_IMMUNOPROLIFERATIVE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF4
Parent code in ICD-10 C81-C96
Name in latin Morbi immunoproliferativi maligni

Summary Statistics

Key figures

All Female Male
Number of individuals 205 86 119
Unadjusted prevalence (%) 0.06 0.04 0.08
Mean age at first event (years) 66.14 65.11 66.89

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_IMMUNOPROLIFERATIVE – Malignant immunoproliferative diseases
GWS hits:

Survival analyses between endpoints

Plot

before Malignant immunoproliferative diseases
after Malignant immunoproliferative diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Malignant immunoproliferative diseases